Cleared Traditional

K911110 - OPHTA SIL(R), ENULCEATION/EVISCERATION IMPLANTS

K911110 is an FDA 510(k) clearance for OPHTA SIL, manufactured by G.W.B. Intl., Ltd.. The device is a Class 2 Ophthalmic device with product code HPZ cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K911110 · G.W.B. Intl., Ltd. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
106d
Days
Class 2
Risk

K911110 is an FDA 510(k) clearance for the OPHTA SIL(R), ENULCEATION/EVISCERATION IMPLANTS. Classified as Implant, Eye Sphere (product code HPZ), Class II - Special Controls.

Submitted by G.W.B. Intl., Ltd. (Sudbury, US). The FDA issued a Cleared decision on June 18, 1991 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.3320 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all G.W.B. Intl., Ltd. devices

FDA 510(k) Submission Details - K911110

510(k) Number K911110 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 1991
Decision Date June 18, 1991
Days to Decision 106 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 110d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HPZ Device Classification - Class 2, Special Controls

Product Code HPZ Implant, Eye Sphere
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.